IFACT: Incidental Findings in Advanced Cancer Therapy — IFACT  

Breast Cancer Clinical Trial

Official title: IFACT: Incidental Findings in Advanced Cancer Therapy

Status Completed

Clinical Trial Summary

The proposed study, IFACT - Incidental Findings in Advanced Cancer Therapy, will address this research gap by examining MSK patients' attitudes, preferences, and information needs regarding incidental findings arising from tumor genomic profiling.

Clinical Trial Description

Part 1, the investigators will recruit 40 participants from those already enrolled in existing MSK IRB protocol #12-245 (PI: David Hyman, MD) including male and female patients who have been diagnosed with late-stage breast, colorectal, bladder, and lung cancer (some of the most common cancers in this study population).

Part 2, the investigators will recruit 20 participants from those who have actually received incidental germline findings from MSK IRB protocol #12-245 Consent Part C in order to cognitively test novel survey items about their knowledge and perceived utility of their incidental findings (note that the content of these items will be derived from the data collected in Part 1) ;

Related Conditions & MeSH terms

• Bladder Cancer
• Breast Cancer
• Colorectal Cancer
• Colorectal Neoplasms
• Lung Cancer
• Urinary Bladder Neoplasms

• NCT number: NCT02217891
• Study type: Observational
• Source: Memorial Sloan Kettering Cancer Center
• Status: Completed
• Start date: August 2014
• Completion date: February 9, 2023